ATE101513T1 - 5-amino- oder substituierte amino-1,2,3-triazole, verwendbar als antiproliferativa. - Google Patents
5-amino- oder substituierte amino-1,2,3-triazole, verwendbar als antiproliferativa.Info
- Publication number
- ATE101513T1 ATE101513T1 AT88307418T AT88307418T ATE101513T1 AT E101513 T1 ATE101513 T1 AT E101513T1 AT 88307418 T AT88307418 T AT 88307418T AT 88307418 T AT88307418 T AT 88307418T AT E101513 T1 ATE101513 T1 AT E101513T1
- Authority
- AT
- Austria
- Prior art keywords
- amino
- antiproliferants
- triazole
- usable
- substituted amino
- Prior art date
Links
- JSIAIROWMJGMQZ-UHFFFAOYSA-N 2h-triazol-4-amine Chemical class NC1=CNN=N1 JSIAIROWMJGMQZ-UHFFFAOYSA-N 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/087,494 US4847257A (en) | 1987-08-20 | 1987-08-20 | 5-Amino or substituted amino 1,2,3,-triazoles useful as antiproliferative agents |
| EP88307418A EP0304221B1 (de) | 1987-08-20 | 1988-08-11 | 5-Amino- oder substituierte Amino-1,2,3-Triazole, verwendbar als Antiproliferativa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE101513T1 true ATE101513T1 (de) | 1994-03-15 |
Family
ID=22205528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88307418T ATE101513T1 (de) | 1987-08-20 | 1988-08-11 | 5-amino- oder substituierte amino-1,2,3-triazole, verwendbar als antiproliferativa. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US4847257A (de) |
| EP (1) | EP0304221B1 (de) |
| JP (1) | JP2572115B2 (de) |
| KR (1) | KR960014871B1 (de) |
| AT (1) | ATE101513T1 (de) |
| AU (1) | AU612172B2 (de) |
| CA (1) | CA1325977C (de) |
| CY (1) | CY1954A (de) |
| DE (1) | DE3887793T2 (de) |
| DK (1) | DK175915B1 (de) |
| HK (1) | HK107596A (de) |
| IE (1) | IE61719B1 (de) |
| IL (1) | IL87421A (de) |
| NZ (1) | NZ225770A (de) |
| PT (1) | PT88275B (de) |
| ZA (1) | ZA886125B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5498620A (en) * | 1989-05-19 | 1996-03-12 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor 1,2,3-triazolo compounds |
| US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
| US5132315A (en) * | 1989-05-19 | 1992-07-21 | The United States Of America As Represented By The Department Of Health And Human Services | Therapeutic application of an anti-invasive compound |
| US5880129A (en) * | 1989-05-19 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of inhibiting invasion and metastasis of malignant solid tumors |
| ATE192446T1 (de) * | 1990-12-28 | 2000-05-15 | Teijin Ltd | Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel |
| US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
| US5744492A (en) * | 1993-09-17 | 1998-04-28 | United States Of America | Method for inhibiting angiogenesis |
| WO1997003668A1 (en) * | 1995-07-21 | 1997-02-06 | Constantia Gruppe | Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| US5728707A (en) * | 1995-07-21 | 1998-03-17 | Constantia Gruppe | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide |
| US8198334B2 (en) * | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| US7087648B1 (en) * | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
| US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| US6702801B2 (en) * | 1998-05-07 | 2004-03-09 | Kimberly-Clark Worldwide, Inc. | Absorbent garment with an extensible backsheet |
| CA2583110A1 (en) * | 2004-10-04 | 2006-04-20 | Cellgate, Inc. | Polyamine analogs as therapeutic agents for ocular diseases |
| US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| CN101164538B (zh) * | 2006-10-16 | 2011-12-14 | 中国医学科学院基础医学研究所 | 羧胺三唑类化合物及其盐在制备治疗疼痛性疾病和/或炎症性疾病的药物中的应用 |
| US8377973B2 (en) * | 2009-09-04 | 2013-02-19 | Tactical Therapeutics Inc | Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations |
| CN112358451B (zh) * | 2021-01-11 | 2021-04-13 | 广东银珠医药科技有限公司 | 羧胺三唑的合成方法 |
| CN113620892B (zh) * | 2021-10-12 | 2022-02-22 | 广东银珠医药科技有限公司 | 羧胺三唑单晶、制备方法及其组合物和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4590201A (en) * | 1984-02-02 | 1986-05-20 | Merck & Co., Inc. | 5-amino or substituted amino 1,2,3-triazoles |
-
1987
- 1987-08-20 US US07/087,494 patent/US4847257A/en not_active Expired - Lifetime
-
1988
- 1988-08-10 NZ NZ225770A patent/NZ225770A/xx unknown
- 1988-08-11 AT AT88307418T patent/ATE101513T1/de not_active IP Right Cessation
- 1988-08-11 DE DE3887793T patent/DE3887793T2/de not_active Expired - Lifetime
- 1988-08-11 EP EP88307418A patent/EP0304221B1/de not_active Expired - Lifetime
- 1988-08-11 IL IL87421A patent/IL87421A/xx not_active IP Right Cessation
- 1988-08-15 CA CA000574763A patent/CA1325977C/en not_active Expired - Fee Related
- 1988-08-16 PT PT88275A patent/PT88275B/pt not_active IP Right Cessation
- 1988-08-18 ZA ZA886125A patent/ZA886125B/xx unknown
- 1988-08-19 AU AU21159/88A patent/AU612172B2/en not_active Expired
- 1988-08-19 KR KR1019880010519A patent/KR960014871B1/ko not_active Expired - Fee Related
- 1988-08-19 DK DK198804654A patent/DK175915B1/da not_active IP Right Cessation
- 1988-08-19 IE IE255188A patent/IE61719B1/en not_active IP Right Cessation
- 1988-08-20 JP JP63205715A patent/JP2572115B2/ja not_active Expired - Fee Related
-
1989
- 1989-05-08 US US07/348,823 patent/US5045543A/en not_active Expired - Lifetime
-
1996
- 1996-06-19 HK HK107596A patent/HK107596A/en not_active IP Right Cessation
-
1997
- 1997-05-16 CY CY195497A patent/CY1954A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT88275B (pt) | 1995-03-01 |
| DK465488A (da) | 1989-03-15 |
| US5045543A (en) | 1991-09-03 |
| KR890003385A (ko) | 1989-04-14 |
| DE3887793T2 (de) | 1994-07-28 |
| DK465488D0 (da) | 1988-08-19 |
| IE61719B1 (en) | 1994-11-30 |
| IE882551L (en) | 1989-02-20 |
| DE3887793D1 (de) | 1994-03-24 |
| AU612172B2 (en) | 1991-07-04 |
| IL87421A0 (en) | 1989-01-31 |
| DK175915B1 (da) | 2005-06-27 |
| ZA886125B (en) | 1989-04-26 |
| PT88275A (pt) | 1989-06-30 |
| KR960014871B1 (ko) | 1996-10-21 |
| CY1954A (en) | 1997-05-16 |
| IL87421A (en) | 1992-12-01 |
| US4847257A (en) | 1989-07-11 |
| NZ225770A (en) | 1991-11-26 |
| EP0304221A3 (en) | 1990-09-05 |
| CA1325977C (en) | 1994-01-11 |
| JP2572115B2 (ja) | 1997-01-16 |
| EP0304221B1 (de) | 1994-02-16 |
| AU2115988A (en) | 1989-03-16 |
| HK107596A (en) | 1996-06-28 |
| JPS6468321A (en) | 1989-03-14 |
| EP0304221A2 (de) | 1989-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE101513T1 (de) | 5-amino- oder substituierte amino-1,2,3-triazole, verwendbar als antiproliferativa. | |
| DE69203475D1 (de) | Zusammengesetzter Schutzkörper und Verwendung. | |
| DE69108445D1 (de) | Impedanz-gesteuerter Defibrillator. | |
| DE69519997D1 (de) | Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten | |
| ES2184077T3 (es) | Nuevas fenantridinas sustituidas en la posicion 6. | |
| DE59001778D1 (de) | Tragbares atemschutzgeraet. | |
| DE3851533D1 (de) | Behandlung von klimaanlagen. | |
| DK245689A (da) | Bacillus thuringiensis transformationer | |
| DE58902899D1 (de) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. | |
| ATE41773T1 (de) | 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon. | |
| AU1146083A (en) | 2,3-diaryl-5-halo thiophenes | |
| DE69432590D1 (de) | 1,2,3,4-tetrahydrochinolin-2,3,4-trion-3 oder 4-oxime und ihre verwendung | |
| NO892505L (no) | Behandling av vandige dispersjoner. | |
| DE69013871D1 (de) | 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva. | |
| TR199802200A2 (xx) | S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi. | |
| DE69114000D1 (de) | Hochfeste kordel. | |
| DE69101652D1 (de) | Behandlungsofen. | |
| FI962506L (fi) | Psoriasiksen hoito | |
| IT1239171B (it) | Apparecchio di trattamento elettronico di documenti per verificarne l'ortografia. | |
| DE69021162D1 (de) | Substituierte Dibenzonfurane und ihre Verwendung. | |
| DE58908686D1 (de) | Lederbehandlungsmittel. | |
| IT8821688A0 (it) | Macinacaffe'. | |
| FI904234A0 (fi) | Processingsystem foer en televisionssignal foer minskande av diagonala stoerningar i en bild. | |
| ATE66218T1 (de) | 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva. | |
| DE69910608D1 (de) | Neue therapeutische verwendung von 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |